Advisory Board and Editors Microbiology
Corinne F Maurice
CIFAR Azrieli Global Scholar and Tier 2 Canada Research Chair in Gut Microbial Physiology in the Department of Microbiology and Immunology at McGill University. Board member of the Microbiome and Disease Tolerance Centre.
Research in our lab aims to address two major goals:
* Identify and characterize the metabolically active microbial members of the gut microbiota.
* Determine the role of bacteriophages as regulators of the active gut microbiota.
Ian R McDonald
BSc (Hons) University of Ulster, PhD Liverpool University. Postdoc and NERC Advanced Research Fellow at Warwick University. I have been at the University of Waikato since 2004 and was promoted to Professor in 2018. My research has focused on the microbial ecology of methane oxidation, Antarctica and geothermal environments in New Zealand. In Antarctica we are studying the drivers of microbial diversity in Dry Valley soils, geothermal environments (Mts Erebus, Melbourne and Rittmann), and terrestrial meltwater ponds. Currently ‘The 1000 Spring project’ is determining drivers of microbial diversity in NZ geothermal environments. I have organized several NZ and international conferences, I am currently the Chief Officer of SCAR Life Sciences.
John J. Mekalanos
John Mekalanos is the Adele H. Lehman Professor of Microbiology and Molecular Genetics at Harvard Medical School. He has served as Chair of the Microbiology and Molecular Genetics Department since 1996, and he is a member of the National Academy of Sciences and the American Academy of Microbiology.
Dr. Mekalanos has received amongst other honors the Eli Lilly Award and American Association for the Advancement of Science Newcomb Cleveland Prize for the Outstanding Paper of 1993 Published in Science (259:686-688, 1993). He has been a member of the FDA Advisory Committee on Vaccines and Related Biologics, and has consulted for numerous other governmental and private agencies, including NIH, DOD, the World Health Organization, The International Vaccine Institute, the National Academy of Sciences, Massachusetts Public Health Biological Laboratories, and the US-Japan Cooperative Medical Science Program. Dr. Mekalanos has been an active consultant in the pharmaceutical industry for companies including SmithKline, Merck, and Vicuron, and he was a co-founder of three biotechnology firms (Virus Research Institute, PharmAthene and most recently, Matrivax). He received the Sanofi-Institut Pasteur 2012 Award. He and his group have published over 200 research articles, and he has supervised more than 50 trainees in his lab during his career thus far.
Maria Miragaia
Auxiliary Researcher at Laboratory of Bacterial Evolution and Molecular Epidemiology, Instituto de Tecnologia Quimica e Biologica, Universidade Nova de Lisboa, Portugal. Recipient of the 2010 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Grant and of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Infectious Diseases fellows Award.
Arindam Mitra
Dr. Arindam Mitra is a Professor of Microbiology with a specialization in Molecular Biology and Microbiology. He received his Ph.D. from the University of Maryland, College Park, Maryland, USA. After his doctoral studies, Dr. Mitra also worked as a postdoctoral researcher at the Arizona State University, Tempe, USA.
Dr. Mitra's research area includes microbial pathogenesis, biofilms, and vaccine development. Currently, he examines the development and regulation of biofilms in natural, industrial, and clinical settings.
He serves as a reviewer for several peer-reviewed scientific journals such as Food Research International, Access Microbiology, Journal of Medical Microbiology, Frontiers in Immunology, Frontiers in Microbiology, and many others. Dr. Mitra also serves as an editor for Access Microbiology, Microbiology Today, Canadian Journal of Infectious Diseases and Medical Microbiology, and Peer J Life and Environment.
Edward Mocarski
Professor Emeritus, Stanford University (2006) and Emory University (2021). Formerly, Robert W. Woodruff Professor of Microbiology and Immunology in the Emory Vaccine Center at Emory University (2006-2021) and Professor and Chair of Microbiology & Immunology at Stanford University (1983 - 2006). Previously (2009 and 2010), Distinguished Fellow at MedImmune, LLC, a wholly owned subsidiary of AstraZeneca.
Pia H Moisander
Dr. Pia Moisander is a marine microbial ecologist and a Professor at the Department of Biology and the Department of Estuarine and Ocean Sciences at the University of Massachusetts Dartmouth. Her primary research focus is on the marine nitrogen fixation, microbiomes, biofilms, and microbial community assembly.
Héctor Manuel Mora-Montes
In 2010, I established the Laboratory of Fungal Glycobiology at Universidad de Guanajuato, Mexico, with the main goal to understand the synthesis mechanisms of the fungal cell wall and the interaction of medically relevant fungal pathogens with the host. This laboratory is characterized by its facilities to perform chemical, immunological, genetic, molecular, and cellular analyses of human fungal pathogens. Therefore, it is among a handful of research facilities within Mexico and Latin America offering a multidisciplinary and integral approach to understand the host-fungus interaction. Our group has a solid international reputation in the molecular and immunological studies of organisms belonging to the genus Candida and Sporothrix.
Xosé Anxelu G. Morán
Research Professor at the Oceanographic Center of Gijón/Xixón (IEO, CSIC), Spain. I was Associate Professor of Marine Science, Red Sea Research Center, King Abdullah University of Science and Technology (KAUST), Saudi Arabia, from 2014 to 2020 (currently adjunct). I joined the IEO in 2001 after my PhD training at the Institute of Marine Sciences (ICM, CSIC) in Barcelona. I am a biological oceanographer and microbial ecologist addressing the role of microbial plankton in biogeochemical carbon cycling from different perspectives. My research interests include the trophic relationships between phytoplankton and heterotrophic prokaryotes, the long-term dynamics of planktonic microorganisms and their response to global change, with particular emphasis on warming using the metabolic ecology framework. I combine experimental approaches with large-scale observations, both spatial and temporal, in order to predict the future direction and extent of change in the structure and functioning of marine microbial food webs.
Monika Mortimer
Senior Researcher at the National Institute of Chemical Physics and Biophysics, Tallinn, Estonia. Research interests and experience include ecotoxicology, environmental effects of engineered nanomaterials, fate and transport of contaminants of emerging concern, and microbiology.
Craig L Moyer
My specialty is the marine microbial ecology and geomicrobiology of hydrothermal vent systems. I also maintain interests in terrestrial and aquatic microbial ecology, microbe-macrobe symbiotic relationships, bioremediation and microbial cycles that impact global climate change. My focus has been the study of microbial mats in and around hydrothermal vents, this includes the biodiversity and biogeography of the Zetaproteobacteria.
Garry Myers
PhD (1999) at U. Sydney, followed by a postdoc at The Institute for Genome Research (TIGR). I joined the TIGR Faculty in 2005. In 2007, I was a co-founder of the Institute for Genome Sciences at the University of Maryland School of Medicine. In 2014, I joined the ithree Institute at the University of Technology Sydney as Associate Professor. My research interests are the application of bioinformatics and genomic-scale tools to bacterial pathogens and the host response, particularly Chlamydia.